N(6)-(N-threonylcarbonyl)adenosine
anticodon adjacent nucleoside; occurs at3'end of anticodon in most tRNA's whih read codons beginning with adenosine;RN given refers to (L)-isomer
Also Known As:
N(6)-(N-threonylcarbonyl)adenosine, (D)-isomer; N-((9-beta-D-ribofuranosylpurin-6-yl)-carbamoyl)threonine; N-(9-(beta-D-ribofuranosyl)purin-6-ylcarbamoyl)threonine; N-(purin-6-ylcarbamoyl)-L-threonine riboside; N6-threonylcarbamoyladenosine; t(6)a; L-Threonine, N-(((9-beta-D-ribofuranosyl-9H-purin-6-yl)amino)carbonyl)-
Networked: 4
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Bruch, Alexander:
1 article
(01/2017)
|
2. | Klassen, Roland:
1 article
(01/2017)
|
3. | Schaffrath, Raffael:
1 article
(01/2017)
|
4. | Kimura, Satoshi:
1 article
(02/2013)
|
5. | Miyauchi, Kenjyo:
1 article
(02/2013)
|
6. | Suzuki, Tsutomu:
1 article
(02/2013)
|
7. | Bu, Shan-Shan:
1 article
(05/2009)
|
8. | Han, Dong:
1 article
(05/2009)
|
9. | Li, Hua-Yu:
1 article
(05/2009)
|
10. | Li, Juan:
1 article
(05/2009)
|
Related Diseases
1. | Dehydration (Water Stress)
|
2. | Neoplasms (Cancer)
05/01/2009
- " In this manner, numerous modified purine nucleosides were identified in the urine samples from cancer patients including xanthine, adenosine, N1-methyladenosine, 5'-deoxy-5'-methylthioadenosine, 2-methyladenosine, N6-threonylcarbamoyladenosine, inosine, N1-methylinosine, guanosine, N1-methylguanosine, N7-methylguanine, N2-methylguanosine, N2,N2-dimethyguanosine, N2,N2,N7-trimethylguanosine. "
|
3. | COVID-19
|
|
Related Drugs and Biologics